BioSpace News Archive

Business

Takeda Inks Potential $2.2B Deal for AC Immune’s Alzheimer’s Immunotherapy

Takeda on Monday said it is paying AC Immune $100 million upfront for an option on a Phase Ib/II Alzheimer’s disease candidate that could activate the immune system to clear amyloid beta plaques.

May 13, 2024
·
2 min read
·
Nick Paul Taylor
Drug Development

Merck Ends Phase III Anti-TIGIT, Keytruda Skin Cancer Study with High Dropouts

A pre-planned analysis revealed patients receiving the vibostolimab-Keytruda coformulation in a late-stage trial had a high rate of dropouts due to immune-related adverse events, Merck announced Monday.

May 13, 2024
·
2 min read
·
Kate Goodwin
Drug Development

As Sales of Weight Loss Drugs Skyrocket, the Insulin Market Falters

Crackdowns on drug pricing have forced one major insulin out of the market. Are more to come?

May 13, 2024
·
5 min read
·
Karen Fischer
Drug Development

Excision’s CRISPR-Based HIV Treatment Fails to Show Curative Potential in Early Study

Results from a Phase I study presented Friday at the ASGCT 2024 annual meeting showed that despite a good safety profile, Excision BioTherapeutics’ HIV gene editor failed to suppress viral activity.

May 13, 2024
·
2 min read
·
Tristan Manalac
Policy

BIOSECURE Act Gets Update, Gives US Drugmakers Until 2032 to Sever Ties with Chinese Biotechs

An updated draft of the BIOSECURE Act introduced on Friday would give U.S. drug manufacturers additional leeway for existing contracts with certain Chinese “companies of concern” until 2032.

May 13, 2024
·
2 min read
·
Tristan Manalac
Policy

Sanofi, Pfizer, AstraZeneca Pledge Nearly $2.16B in Total Investments in France

The major biopharma players have promised to increase their investments in France to help boost their respective global manufacturing and R&D capabilities, with Sanofi committing more than $1 billion.

May 13, 2024
·
2 min read
·
Tristan Manalac
BioMidwest

3M Announces Upcoming Investor Event - May 13, 2024

3M announced the following investor event in partnership with Montrose Environmental Group, Inc.

May 13, 2024
·
1 min read
Genetown

Laborie Unveils Positive Study Results for Optilume® BPH Catheter System

Laborie Medical Technologies Corp., a leading diagnostic and therapeutic medical technology company, announced positive 2-year and 5-year results from studies for its Optilume® BPH Catheter System.

May 13, 2024
·
2 min read
Business

Leap Therapeutics Reports First Quarter 2024 Financial Results

Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported financial results for the first quarter ended March 31, 2024.

May 13, 2024
·
13 min read
Pharm Country

GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications

GenScript Biotech Corporation, a global leader in life science research tools and services, has announced the expansion of its in vitro transcription RNA synthesis portfolio to include self-amplifying RNA.

May 13, 2024
·
4 min read